Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
9.53M
-
Shares change
-
+9.53M
-
Total reported value, excl. options
-
$138M
-
Value change
-
+$138M
-
Number of buys
-
50
-
Price
-
$14.63
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2018
50 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q1 2018.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.53M shares
of 53M outstanding shares and own 17.96% of the company stock.
Largest 10 shareholders include Polaris Venture Management Co. V, L.L.C. (2.64M shares), DISCOVERY CAPITAL MANAGEMENT, LLC / CT (1.5M shares), FMR LLC (1.43M shares), JENNISON ASSOCIATES LLC (811K shares), Voya Investment Management LLC (475K shares), FEDERATED INVESTORS INC /PA/ (400K shares), WELLINGTON MANAGEMENT GROUP LLP (362K shares), BlackRock Inc. (234K shares), Empyrean Capital Partners, LP (202K shares), and VANGUARD GROUP INC (184K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.